STAFFORD, Texas, March 17, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial ...

After hours: March 21 at 6:24:45 PM EDT Loading Chart for GLSI ...

With more than 20 years of real estate and infrastructure investment experience, Mike returns to GI Partners from Stream Data ...

23andMe has filed for Chapter 11 bankruptcy protection and its co-founder and CEO has resigned as the struggling genetic ...

Digital Asset, which creates software for digital asset management and financial markets, has signed a 10-year lease for 12,000 square feet on the entire 17th floor of Trinity Church Wall Street’s 107 ...

Shvo’s 530 Broadway has gone to Plaid. The San Francisco-based fintech firm signed a deal for 45,300 square feet at the corner of Broadway and Spring Street, where it plans to relocate and expand its ...

Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart ...

Medtel, a leading healthcare technology company specializing in surgical care coordination, is pleased to announce the appointment of Dr. Richard Iorio as Senior Advisor. A nationally recognized ...

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. The company offers ...

Zydus Lifesciences Ltd share price was down by -1.77% from the previous closing price of ₹923.70. Who are peers of Zydus Lifesciences Ltd? The peers of Zydus Lifesciences Ltd are Sun ...